Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H21O11.Cl |
Molecular Weight | 484.838 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].OC[C@H]1O[C@@H](OC2=C([O+]=C3C=C(O)C=C(O)C3=C2)C4=CC=C(O)C(O)=C4)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChIKey=YTMNONATNXDQJF-UBNZBFALSA-N
InChI=1S/C21H20O11.ClH/c22-7-16-17(27)18(28)19(29)21(32-16)31-15-6-10-12(25)4-9(23)5-14(10)30-20(15)8-1-2-11(24)13(26)3-8;/h1-6,16-19,21-22,27-29H,7H2,(H3-,23,24,25,26);1H/t16-,17-,18+,19-,21-;/m1./s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Cyanidin-3-glucoside suppresses B[a]PDE-induced cyclooxygenase-2 expression by directly inhibiting Fyn kinase activity. | 2011 Jul 15 |
|
Malvidin-3-glucoside protects endothelial cells up-regulating endothelial NO synthase and inhibiting peroxynitrite-induced NF-kB activation. | 2012 Sep 30 |
|
Effects of anthocyanins on the AhR-CYP1A1 signaling pathway in human hepatocytes and human cancer cell lines. | 2013 Jul 31 |
|
Cyanidin-3-O-glucoside modulates intracellular redox status and prevents HIF-1 stabilization in endothelial cells in vitro exposed to chronic hypoxia. | 2014 Apr 21 |
|
Palmitate-induced endothelial dysfunction is attenuated by cyanidin-3-O-glucoside through modulation of Nrf2/Bach1 and NF-κB pathways. | 2015 Dec 15 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8X15R84UEM
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | |||
|
7084-24-4
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | |||
|
8X15R84UEM
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | |||
|
CHRYSANTHEMIN
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | |||
|
1151935
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | |||
|
DTXSID401028798
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | |||
|
C066411
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | |||
|
m3947
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | Merck Index | ||
|
230-384-7
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY | |||
|
197081
Created by
admin on Fri Dec 15 19:47:41 GMT 2023 , Edited by admin on Fri Dec 15 19:47:41 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD